Surgery for Metastatic UTUC May Boost Survival Over Non-Surgical Options: Review Findings

What is it about?

This systematic review and meta-analysis evaluates the impact of primary tumour surgery on survival outcomes in patients with metastatic upper urinary tract urothelial carcinoma (mUTUC). By analyzing ten retrospective studies, the research indicates that primary tumour surgery significantly improves survival outcomes, including progression-free survival, cancer-specific survival, and overall survival, compared to systemic therapies alone. The study finds that surgery, especially in younger patients and those with a single metastatic site, is associated with better outcomes. Despite these findings, the evidence is primarily from retrospective studies, highlighting the need for prospective studies to confirm the benefits and identify which patients may benefit most from surgical intervention. The study adheres to the PRISMA guidelines and includes data extracted from various databases, focusing on adult patients diagnosed with mUTUC.

Featured Image

Why is it important?

This research is crucial as it explores the impact of primary tumor surgery on survival outcomes in patients with metastatic upper urinary tract urothelial carcinoma (mUTUC), a challenging condition with poor prognosis. By conducting a systematic review and meta-analysis, the study aims to clarify whether surgical intervention can improve survival compared to non-surgical management options. The findings could inform clinical decision-making and potentially lead to better tailored treatment strategies for patients with mUTUC. Furthermore, the study highlights the need for prospective studies to establish definitive criteria for patient selection, thereby advancing personalized medicine in this area. Key Takeaways: 1. Survival Outcomes: The research indicates that primary tumor surgery is associated with improved survival outcomes, including overall survival (OS) and cancer-specific survival (CSS), especially when combined with systemic therapy (STx), compared to non-surgical management. 2. Patient Selection: Younger patients and those with a single metastatic site appear to benefit the most from surgical intervention, emphasizing the importance of careful patient selection to maximize the potential benefits of surgery. 3. Need for Prospective Studies: The current evidence is primarily based on retrospective studies, which may have selection biases, underscoring the necessity for prospective research to validate findings and establish clear guidelines for surgical intervention in mUTUC patients.